famotidine has been researched along with Torsade de Pointes in 3 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate spontaneous reports of TdP present in the public version of the FDA Adverse Event Reporting System (AERS) in the light of what is already known on their TdP-liability." | 1.35 | Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS). ( De Ponti, F; Moretti, U; Poluzzi, E; Raschi, E, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poluzzi, E | 1 |
| Raschi, E | 1 |
| Moretti, U | 1 |
| De Ponti, F | 1 |
| Sugiyama, A | 1 |
| Satoh, Y | 1 |
| Takahara, A | 1 |
| Nakamura, Y | 1 |
| Shimizu-Sasamata, M | 1 |
| Sato, S | 1 |
| Miyata, K | 1 |
| Hashimoto, K | 1 |
| Thompson, C | 1 |
| Tsiperfal, A | 1 |
3 other studies available for famotidine and Torsade de Pointes
| Article | Year |
|---|---|
Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS).
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Anti-Bacterial Agents; Antidepressive Agents; A | 2009 |
Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems.
Topics: Action Potentials; Animals; Cation Transport Proteins; Cell Line; DNA-Binding Proteins; Dogs; Electr | 2003 |
Why is the QT interval measurement so critical when evaluating an ECG rhythm?
Topics: Aged; Aged, 80 and over; Electrocardiography; Famotidine; Heart Conduction System; Histamine H2 Anta | 2003 |